Lvw Advisors, LLC Gilead Sciences, Inc. Transaction History

Lvw Advisors, LLC

$771 Million
Q3 2024

A detailed history of Lvw Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Lvw Advisors, LLC holds 18,819 shares of GILD stock, worth $1.7 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

18,819

Previous 16,880 11.49%

Holding current value

$1.7 Million

Previous $1.16 Million 36.18%

% of portfolio

0.2%

Previous 0.17%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	BUY	$66.59 - $83.99 $129,118 - $162,856	1,939 Added 11.49%	18,819 $1.58 Million
Q2 2024 Jul 15, 2024	SELL	$63.15 - $72.88 $549,405 - $634,056	-8,700 Reduced 34.01%	16,880 $1.16 Million
Q1 2024 Apr 17, 2024	BUY	$71.58 - $87.29 $660,182 - $805,075	9,223 Added 56.39%	25,580 $1.87 Million
Q4 2023 Jan 12, 2024	BUY	$73.27 - $83.09 $376,754 - $427,248	5,142 Added 45.85%	16,357 $1.33 Million
Q3 2023 Oct 10, 2023	BUY	$73.94 - $80.67 $419,609 - $457,802	5,675 Added 102.44%	11,215 $840,000
Q2 2023 Jul 14, 2023	SELL	$76.01 - $86.7 $30,099 - $34,333	-396 Reduced 6.67%	5,540 $426,000
Q1 2023 May 02, 2023	BUY	$77.31 - $88.08 $38,500 - $43,863	498 Added 9.16%	5,936 $492,000
Q4 2022 Jan 18, 2023	SELL	$62.32 - $89.47 $685 - $984	-11 Reduced 0.2%	5,438 $0
Q3 2022 Oct 13, 2022	BUY	$59.54 - $68.01 $297 - $340	5 Added 0.09%	5,449 $336,000
Q2 2022 Jul 22, 2022	SELL	$57.72 - $65.01 $288 - $325	-5 Reduced 0.09%	5,444 $336,000
Q1 2022 May 02, 2022	BUY	$57.92 - $72.58 $2,432 - $3,048	42 Added 0.78%	5,449 $324,000
Q4 2021 Jan 26, 2022	SELL	$64.88 - $73.64 $58,586 - $66,496	-903 Reduced 14.31%	5,407 $393,000
Q2 2021 Jul 15, 2021	SELL	$63.47 - $69.35 $16,375 - $17,892	-258 Reduced 3.93%	6,310 $435,000
Q1 2021 Apr 19, 2021	BUY	$60.0 - $68.46 $16,200 - $18,484	270 Added 4.29%	6,568 $424,000
Q4 2020 Feb 04, 2021	SELL	$56.65 - $64.55 $12,293 - $14,007	-217 Reduced 3.33%	6,298 $367,000
Q3 2020 Oct 29, 2020	BUY	$62.1 - $78.08 $123,951 - $155,847	1,996 Added 44.17%	6,515 $412,000
Q2 2020 Aug 11, 2020	SELL	$72.34 - $84.0 $21,846 - $25,368	-302 Reduced 6.26%	4,519 $348,000
Q1 2020 Apr 23, 2020	SELL	$62.63 - $80.22 $43,590 - $55,833	-696 Reduced 12.62%	4,821 $360,000
Q3 2019 Oct 22, 2019	BUY	$62.51 - $69.0 $81,137 - $89,562	1,298 Added 30.77%	5,517 $350,000
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $261,029 - $292,714	4,219 New	4,219 $285,000

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lvw Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lvw Advisors, LLC with notifications on news.

Account